Literature DB >> 20857143

Murine immune response induced by Leishmania major during the implantation of paraffin tablets.

Maria Letícia Costa Reis1, Vanessa Martins Ferreira, Xia Zhang, Ricardo Gonçalves, Leda Quércia Vieira, Washington Luiz Tafuri, David M Mosser, Wagner Luiz Tafuri.   

Abstract

We carried out a model of chronic inflammation using a subcutaneous paraffin tablet in mice experimentally infected with Leishmania major. It was previously reported that the parasite load following paraffin implantation occurred at a peak of 21 days in both BALB/c and C57BL/6 mice. At the present study, we have investigated what cytokines and chemokines are directly related to the parasite load in C57BL/6 mice. All mice were divided in four groups: mice implanted with paraffin tablets; mice experimentally infected with L. major; mice implanted with paraffin tablets and experimentally infected with L. major; and mice submitted only to the surgery were used for the Real-Time Polymerase Chain Reaction (RT-PCR) controls. Fragments of skin tissue and the tissue surrounding the paraffin tablets (inflammatory capsule) were collected for histopathology and RT-PCR studies. By 21 days, a diffuse chronic inflammatory reaction was mainly observed in the deep dermis where macrophages parasitized with Leishmania amastigotes were also found. RT-PCR analysis has shown that BALB/c mice showed strong IL-4 and IL-10 mRNA expression than controls with very little expression of IFN-γ. In contrast, both IFN-γ and IL-10 mRNA was found in higher levels in C57BL/6 animals. Moreover, in C57BL/6 mice the expression of chemokines mRNA of CCL3/MIP-1α was more highly expressed than CCL2/MCP-1. We conclude that the Th1 immune response C57BL/6 did not change to a Th2 response, even though C57BL/6 animals presented higher parasitism than BALB/c mice 21 days after infection and paraffin implantation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20857143      PMCID: PMC3057163          DOI: 10.1007/s00428-010-0974-9

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  38 in total

1.  Disseminated cutaneous leishmaniasis: a patient with 749 lesions.

Authors:  Anastácio Q Sousa; Margarida M L Pompeu; F R Neves Sólon; Mércia S Frutuoso; M Jania Teixeira; Terezinha M J Silva
Journal:  Braz J Infect Dis       Date:  2006-06       Impact factor: 1.949

2.  Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide.

Authors:  F Y Liew; Y Li; S Millott
Journal:  J Immunol       Date:  1990-12-15       Impact factor: 5.422

3.  Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite.

Authors:  A Diefenbach; H Schindler; N Donhauser; E Lorenz; T Laskay; J MacMicking; M Röllinghoff; I Gresser; C Bogdan
Journal:  Immunity       Date:  1998-01       Impact factor: 31.745

4.  The role of IL-10 in promoting disease progression in leishmaniasis.

Authors:  M M Kane; D M Mosser
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

5.  Involvement of the chemokine RANTES (CCL5) in resistance to experimental infection with Leishmania major.

Authors:  Helton da Costa Santiago; Carolina Ferreira Oliveira; Luciana Santiago; Fernanda Oliveira Ferraz; Daniele da Glória de Souza; Luiz Antônio Rodrigues de-Freitas; Luís Carlos Crocco Afonso; Mauro Martins Teixeira; Ricardo Tostes Gazzinelli; Leda Quercia Vieira
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

Review 6.  Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies.

Authors:  Christine Daly; Barrett J Rollins
Journal:  Microcirculation       Date:  2003-06       Impact factor: 2.628

7.  IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis.

Authors:  P Scott
Journal:  J Immunol       Date:  1991-11-01       Impact factor: 5.422

8.  Fibroblasts as host cells in latent leishmaniosis.

Authors:  C Bogdan; N Donhauser; R Döring; M Röllinghoff; A Diefenbach; M G Rittig
Journal:  J Exp Med       Date:  2000-06-19       Impact factor: 14.307

9.  CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis.

Authors:  Charles F Anderson; Mohammed Oukka; Vijay J Kuchroo; David Sacks
Journal:  J Exp Med       Date:  2007-02-05       Impact factor: 14.307

10.  Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity.

Authors:  E von Stebut; Y Belkaid; T Jakob; D L Sacks; M C Udey
Journal:  J Exp Med       Date:  1998-10-19       Impact factor: 14.307

View more
  1 in total

1.  Nucleotides and AHCC Enhance Th1 Responses In Vitro in Leishmania-Stimulated/Infected Murine Cells.

Authors:  María Auxiliadora Dea-Ayuela; Sergi Segarra; Dolores R Serrano; Francisco Bolás-Fernández
Journal:  Molecules       Date:  2020-08-27       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.